Researchers hope to improve survival rates through early detection with a blood test that can detect over 50 types of cancer.

Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...

Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

MADISON, Wis., September 10, 2025 — Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...

Combining virtual dental care with licensed dentists and an innovative oral cancer diagnostics solution ensures all ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...

When Jayant Parthasarathy lost family members to breast, brain, ovarian, and prostate cancers, his next mission was clear.

After becoming a patient himself following a recent cancer diagnosis, a local doctor said he wants to share his story to ...

Several area organizations are using quilts to raise public awareness of the importance of early screening for cervical ...